16th European Meeting on HIV & Hepatitis 2018
The European Meeting on HIV & Hepatitis is the premier European platform for clinicians, allied healthcare providers, researchers and clinical virologists to discuss the latest developments in antiviral therapy for HIV, HCV and HBV and for translating them into new treatment strategies to further improve clinical care.
Founded sixteen years ago as the European HIV resistance workshop, the meeting evolved to embrace all aspects of clinical care of people living with HIV in Europe. Particular emphasis is put on optimal treatment strategies, clinical virology, molecular epidemiology and public health aspects of HIV, HBV and HCV infections throughout Europe.
In the last decade the meeting has been able to capture leading clinicians and researchers from the different regions of Europe. As such, this meeting is the only European platform where HIV treating physicians and clinical virologists get together on an annual basis to present their latest research results and discuss their clinical implications in detail. The workshop has put a special emphasis on training young clinicians and scientists through clinical case discussions and parallel courses in collaboration with the European Society for Antiviral Research (ESAR).
More details about the Meeting can be found on the official web-site.
Related News
Roundtable organized by Global Fund
On 26 May (Russian) and 27 May (English) at 10.00 am (Geneva time) Developing Country NGO delegation of the Global Fund Board and the Global Fund Secretariat are organizing the Roundtable “Responses to HIV and TB in times of COVID-19 – strengthening engagement with civil society and communities in Eastern Europe and Central Asia (EECA)” Read more
COVID-19 lessons: what can make the HIV programs in the EECA countries more sustainable? (LIVE discussion)
On May 5, 2020, from 11:00 a.m. to 1:00 p.m. EST (UTC+3), Alliance for Public Health will conduct a special LIVE discussion will be held on opportunities to improve the sustainability of national HIV programs that have emerged in connection with COVID-19. Read morePartners
